AbCellera antibody gets US FDA EUA as monotherapy for COVID-19 treatment
AbCellera’s partner, Eli Lilly and Company, will supply the US government with 300,000 doses of bamlanivimab for allocation to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
NIAID
COVAXIN to boost immune response, longer-lasting immunity with ViroVax’s adjuvant
Bharat Biotech has announced its novel coronavirus vaccine COVAXIN approved for human trials, will use adjuvant Alhydroxiquim-II…
Baricitinib in combination with remdesivir reduces recovery time in hospitalised COVID-19 patients:…
Data from the Adaptive COVID-19 Treatment Trial (ACTT-2) revealed an approximately one-day reduction in median recovery time for…
American Gene Technologies gets US FDA nod for Phase 1 clinical trial of potential HIV cure
AGT’s Phase 1 trial will investigate the safety of AGT103-T, a single-dose, lentiviral vector-based gene therapy, and measure key…